A Conversation with the 47th Vice President of the United States Joe Biden

Focused Ultrasound Innovation and Clinical Applications

• Technology Overview: Focused ultrasound is a non-invasive therapeutic technology using intersecting sound beams to treat deep-tissue targets with extreme precision without incisions.
  • Mechanism of Action: Individual ultrasound beams pass through tissue without effect; at the focal point where they converge, they generate heat, destroy tissue, deliver high-concentration drugs, or stimulate immune responses.
  • Current Scope: The field has expanded from 3 indications 10 years ago to over 80 current indications in various stages of development.
  • Target Conditions: Potential applications include Alzheimer's, Parkinson's, epilepsy, OCD, depression, and tumors of the brain, breast, pancreas, and prostate.
• Clinical Case Studies:
  • Pediatric Tumor Case: A six-year-old girl with an uncontrollable pelvic tumor was treated experimentally; focused ultrasound destroyed over 50% of the tumor in one session, relieving pain within two days and restoring renal function within two weeks.
  • Parkinson's Treatment: Patients previously reliant on wheelchairs due to uncontrollable leg movements and pain reported restored mobility, including walking, running, and cycling, following treatment.
  • Intracranial Aneurysms: Mortality and morbidity for aneurysms have dropped from over 50% in the 1980s (requiring major craniotomy) to less than 1% today via non-invasive catheter-based coiling.
• Barriers and Initiatives:
  • Adoption Challenges: The transition from concept to standard of care is a "glacial process" hindered by lack of awareness and the perception of the technology as "snake oil."
  • Public Awareness Strategy: The Focused Ultrasound Foundation utilized a 44-page book by author John Grisham to educate stakeholders, resulting in over 800,000 copies distributed.
  • Limitations: The technology is not a panacea; efficacy varies by patient and specific medical condition.

The Biden Cancer Initiative and Policy Reform

• Origins and Mandate: Launched by Vice President Joe Biden following the death of his son, Beau Biden, from glioblastoma, the initiative aims to accelerate cancer research and treatment through cultural and structural reform.
  • Core Philosophy: The effort focuses on breaking down institutional silos that hinder collaboration and data sharing within the research ecosystem.
  • Key Achievement: A "Blue Ribbon Panel" identified over 80 specific changes, prioritizing high-impact, cost-effective interventions.
• Structural Reforms:
  • Interagency Collaboration: Established a task force including the VA, NIH, NCI, and Department of Energy to aggregate data; the VA's massive tissue and genome data is now processed by DOE supercomputers.
  • National Cancer Institute Formulary: Created a "jukebox" model for clinical trials, allowing researchers to access and combine early-stage drugs from multiple pharmaceutical companies without negotiating separate licenses, reducing development time from years to minutes.
    • Industry Participation: The initiative grew from three initial drug companies to nearly 15 participating firms.
  • Data Sharing: Launched a "Blood Profiling Atlas Pilot" to create an open database for liquid biopsies, aiming to detect cancers years before traditional symptoms appear.
• Legislative and Funding Outcomes:
  • 21st Century Cures Act: Secured bipartisan passage with 388 House votes, providing $1.8 billion in additional funding specifically for cancer research and $6.8 billion total for medical research.
  • Budget Protection: Successfully defended the cancer research budget against proposed cuts, securing a net increase of $476 million for the NCI in the subsequent budget agreement.
  • International Mobilization: Secured memoranda of understanding with 10 global leaders (including China, Australia, Israel, and Jordan) to share cancer data and advance research.
• Future Directives:
  • Biden Cancer Initiative: A new non-profit organization established to continue the work, led by Biden and supported by a team of experts (e.g., David Agus, Eric Lander) to maintain momentum regardless of federal administration changes.
  • Long-term Vision: Goals include turning many cancers into chronic manageable diseases, achieving personalized prevention vaccines, and ensuring the correct therapy is administered during the first treatment attempt.

Personal Narratives and Leadership Philosophy

• Overcoming Adversity: Vice President Biden shared personal history regarding a severe childhood stutter and the death of his first wife and daughter.
  • Impact on Leadership: These experiences fostered a deep sense of empathy and a political strategy of questioning judgment rather than motive, allowing him to serve as a trusted mediator in international negotiations.
  • Family Resilience: The death of his son Beau from cancer in 2015, despite being a decorated war veteran and Attorney General, was the primary catalyst for the Cancer Moonshot.
• Entrepreneurial Roots: Biden detailed his early career founding a law firm at age 26 with a $50,000 loan, highlighting the necessity of balancing public service with financial survival.
  • Philosophy: Emphasized that the "measure of success" is how quickly one recovers from failure, citing his father's advice and the cartoon philosophy of "Why not?" rather than "Why me?"
• Political Strategy:
  • Bipartisanship: Argued that cancer is the only remaining truly bipartisan issue in Washington, successfully uniting Democrats and Republicans to pass major legislation.
  • Party Rebuilding: Proposed a unified Democratic platform that integrates progressive values with working-class economic interests, citing his ability to win over rural, working-class voters with speeches on equal pay and LGBT rights.
  • Future Engagement: Stated a commitment to remain active in policy work through the Biden Institute and the Biden Cancer Initiative rather than seeking elected office immediately.